A Double-Blind, Randomized, Controlled Trial of Lovastatin in Early-Stage Parkinson's Disease.
Chin-Hsien LinChin-Hao ChangChun-Hwei TaiMei-Fang ChengYi-Chieh ChenYing-Ting ChaoTse-Le HuangRuoh-Fang YenRuey-Meei WuPublished in: Movement disorders : official journal of the Movement Disorder Society (2021)
Lovastatin treatment in patients with early-stage PD was associated with a trend of less motor symptom worsening and was well tolerated. A future larger long-term follow-up study is needed to confirm our findings. © 2021 International Parkinson and Movement Disorder Society.